Active-ingredient Dossier
Dolutegravir
Active-ingredient Dossier for Dolutegravir (integrase strand transfer inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: DOVATO
- Brand: JULUCA
- Brand: TIVICAY
- Brand: TRIUMEQ
- Therapeutic area: Infectious Disease
What is
Dolutegravir Dolutegravir is an integrase strand transfer inhibitor.
Australian brands containing
Dolutegravir — DOVATO — JULUCA — TRIUMEQ
Therapeutic areas
Dolutegravir is registered in Infectious Disease, with 3 brands containing this ingredient.
Sponsor landscape
ViiV Healthcare markets dolutegravir in Australia.
PBS and regulatory activity
No brands containing dolutegravir are currently PBS-listed. The latest PBAC outcome was recorded on 1 August 2019, and the latest AusPAR was published on 11 September 2019.